| Authors: |
Sackley CM, Rick C, Brady MC, Woolley R, Burton C, Patel S, Masterson-Algar P, Nicoll A, Smith CH, Jowett S, Ives N, Beaton G, Dickson S, Ottridge R, Nankervis H, Clarke CE |
|
| Title: |
Lee Silverman voice treatment versus NHS speech and language therapy versus control for dysarthria in people with Parkinson’s disease (PD COMM): pragmatic, UK based, multicentre, three arm, parallel group, unblinded, randomised controlled trial |
| Source: |
BMJ 2024 386: Article ID: e078341 |
| Year: |
2024 |
| Research Design: |
Randomised Controlled Trial |
| Rating Score: |
05/10
This rating is confirmed
Eligibility specified - Yes
Random allocation - Yes
Concealed allocation - Yes
Baseline comparability - No
Blind subjects - No
Blind therapists - No
Blind assessors - No
Adequate follow-up - No
Intention-to-treat analysis - Yes
Between-group comparisons - Yes
Point estimates and variability - Yes
|
| Abstract: |
Copyright release for this abstract has not been obtained. |
| Access: |
Open Access |
